Alexander Nowak
Stock Analyst at Craig-Hallum
(2.59)
# 2,130
Out of 4,873 analysts
45
Total ratings
44.44%
Success rate
4.42%
Average return
Main Sectors:
Stocks Rated by Alexander Nowak
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVRX CVRx, Inc. | Maintains: Buy | $20 → $22 | $5.70 | +285.96% | 5 | Jan 17, 2025 | |
| NTRA Natera | Maintains: Buy | $121 → $157 | $170.37 | -7.85% | 4 | Nov 13, 2024 | |
| BVS Bioventus | Maintains: Buy | $12 → $17 | $6.52 | +160.74% | 6 | Sep 27, 2024 | |
| QDEL QuidelOrtho | Upgrades: Buy | $40 → $57 | $27.65 | +106.15% | 6 | Sep 5, 2024 | |
| CELC Celcuity | Assumes: Buy | $25 → $27 | $11.47 | +135.40% | 2 | May 16, 2024 | |
| CDNA CareDx | Upgrades: Buy | $12 → $15 | $18.96 | -20.87% | 3 | May 1, 2024 | |
| DMAC DiaMedica Therapeutics | Assumes: Buy | $8 | $3.63 | +120.39% | 4 | Apr 24, 2024 | |
| LUNG Pulmonx | Initiates: Buy | $18 | $2.57 | +600.39% | 1 | Sep 5, 2023 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $74 → $50 | $20.22 | +147.28% | 2 | Jun 13, 2023 | |
| DRIO DarioHealth | Maintains: Buy | $14 → $8 | $0.69 | +1,067.54% | 1 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $52.54 | - | 1 | Oct 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.67 | - | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $2.11 | +421.33% | 1 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $88 → $110 | $49.30 | +123.12% | 3 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | n/a | $0.50 | - | 2 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $300 | $2.94 | +10,104.08% | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $6.18 | +353.07% | 1 | Aug 31, 2020 |
CVRx, Inc.
Jan 17, 2025
Maintains: Buy
Price Target: $20 → $22
Current: $5.70
Upside: +285.96%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $121 → $157
Current: $170.37
Upside: -7.85%
Bioventus
Sep 27, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $6.52
Upside: +160.74%
QuidelOrtho
Sep 5, 2024
Upgrades: Buy
Price Target: $40 → $57
Current: $27.65
Upside: +106.15%
Celcuity
May 16, 2024
Assumes: Buy
Price Target: $25 → $27
Current: $11.47
Upside: +135.40%
CareDx
May 1, 2024
Upgrades: Buy
Price Target: $12 → $15
Current: $18.96
Upside: -20.87%
DiaMedica Therapeutics
Apr 24, 2024
Assumes: Buy
Price Target: $8
Current: $3.63
Upside: +120.39%
Pulmonx
Sep 5, 2023
Initiates: Buy
Price Target: $18
Current: $2.57
Upside: +600.39%
Tandem Diabetes Care
Jun 13, 2023
Maintains: Buy
Price Target: $74 → $50
Current: $20.22
Upside: +147.28%
DarioHealth
May 12, 2023
Maintains: Buy
Price Target: $14 → $8
Current: $0.69
Upside: +1,067.54%
Oct 19, 2022
Downgrades: Hold
Price Target: n/a
Current: $52.54
Upside: -
Mar 28, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.67
Upside: -
Jan 5, 2022
Initiates: Buy
Price Target: $11
Current: $2.11
Upside: +421.33%
Feb 3, 2021
Maintains: Buy
Price Target: $88 → $110
Current: $49.30
Upside: +123.12%
Jan 20, 2021
Downgrades: Sell
Price Target: n/a
Current: $0.50
Upside: -
Jan 11, 2021
Initiates: Buy
Price Target: $300
Current: $2.94
Upside: +10,104.08%
Aug 31, 2020
Initiates: Buy
Price Target: $28
Current: $6.18
Upside: +353.07%